Literature DB >> 33427914

[The disaster task force medical officer as a pivotal decision maker in the superordinate pandemic hospital capacity management : A field report covering the initial COVID-19 surge in a Bavarian district].

Michael S Dittmar1,2, Jürgen Altmeppen3, Marc U Bigalke4, Florian Niedermirtl5, Markus Zimmermann6.   

Abstract

BACKGROUND AND
OBJECTIVE: During the initial phase of the COVID-19 pandemic the government of the state of Bavaria, Germany, declared a state of emergency for its entire territory for the first time in history. Some areas in eastern Bavaria were among the most severely affected communities in Germany, prompting authorities and hospitals to build up capacities for a surge of COVID-19 patients. In some areas, intensive care unit (ICU) capacities were heavily engaged, which occasionally made a redistribution of patients necessary.
MATERIAL AND METHODS: For managing COVID-19-related hospital capacities and patient allocation, crisis management squads in Bavaria were expanded by disaster task force medical officers ("Ärztlicher Leiter Führungsgruppe Katastrophenschutz" [MO]) with substantial executive authority. The authors report their experiences as MO concerning the superordinate patient allocation management in the district of Upper Palatinate (Oberpfalz) in eastern Bavaria.
RESULTS: By abandoning routine patient care and building up additional ICU resources, surge capacity for the treatment of COVID-19 patients was generated in hospitals. In parts of the Oberpfalz, ICU capacities were almost entirely occupied by patients with corona virus infections, making reallocation to other hospitals within the district and beyond necessary. The MO managed patient pathways in an escalating manner by defining local (within the region of responsibility of a single MO), regional (within the district), and cross-regional (over district borders) reallocation lanes, as needed. When regional or cross-regional reallocation lanes had to be established, an additional management level located at the district government was involved. Within the determined reallocation lanes, emitting and receiving hospitals mutually agreed on any patient transfer without explicitly involving the MO, thereby maintaining the established interhospital routine transfer procedures. The number of patients and available treatment resources at each hospital were monitored with the help of a web-based treatment capacity registry. If indicated, reallocation lanes were dynamically revised according to the present situation. To oppose further virus spreading in nursing homes, the state government prohibited patient allocation to these facilities, which led to considerably longer hospital length of stay of convalescent elderly and/or dependent patients. In parallel to the flattening of the COVID-19 incidence curve, routine hospital patient care could be re-established in a stepwise manner.
CONCLUSION: Patient allocation during the state of emergency by the MO sought to keep up routine interhospital reallocation procedures as much as possible, thereby reducing management time and effort. Occasionally, difficulties were observed during patient allocations crossing district borders, if other MO followed different management principles. The nursing home blockade and conflicting financial interests of hospitals posed challenges to the work of the disaster task force medical officers.

Entities:  

Keywords:  COVID-19; Disaster medicine; Patient transfer; SARS-CoV-2; Surge capacity

Mesh:

Year:  2021        PMID: 33427914      PMCID: PMC7797894          DOI: 10.1007/s00101-020-00911-6

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  5 in total

1.  Seattle's covid-19 lessons are yielding hope.

Authors:  Bryn Nelson
Journal:  BMJ       Date:  2020-04-06

2.  Adaptations and Lessons in the Province of Bergamo.

Authors:  Stefano Fagiuoli; Ferdinando Luca Lorini; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2020-05-05       Impact factor: 91.245

3.  The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study.

Authors:  Qian Liu; Dan Luo; Joan E Haase; Qiaohong Guo; Xiao Qin Wang; Shuo Liu; Lin Xia; Zhongchun Liu; Jiong Yang; Bing Xiang Yang
Journal:  Lancet Glob Health       Date:  2020-04-29       Impact factor: 26.763

4.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.

Authors:  Matthew J Cummings; Matthew R Baldwin; Darryl Abrams; Samuel D Jacobson; Benjamin J Meyer; Elizabeth M Balough; Justin G Aaron; Jan Claassen; LeRoy E Rabbani; Jonathan Hastie; Beth R Hochman; John Salazar-Schicchi; Natalie H Yip; Daniel Brodie; Max R O'Donnell
Journal:  Lancet       Date:  2020-05-19       Impact factor: 79.321

5.  Staying Ahead of the Wave.

Authors:  Adam J Singer; Eric J Morley; Mark C Henry
Journal:  N Engl J Med       Date:  2020-04-13       Impact factor: 91.245

  5 in total
  3 in total

Review 1.  Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.

Authors:  Jan M Stratil; Renke L Biallas; Jacob Burns; Laura Arnold; Karin Geffert; Angela M Kunzler; Ina Monsef; Julia Stadelmaier; Katharina Wabnitz; Tim Litwin; Clemens Kreutz; Anna Helen Boger; Saskia Lindner; Ben Verboom; Stephan Voss; Ani Movsisyan
Journal:  Cochrane Database Syst Rev       Date:  2021-09-15

2.  [Management of COVID-19 mass casualty incidents in nursing and retirement homes].

Authors:  Wolfgang Schreiber; Philipp Wolf; Nicole Bigalke; Marc U Bigalke; Bernhard M Graf; Michael S Dittmar
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-04-20       Impact factor: 0.840

3.  [The role of university hospitals in regional health care management for coping with the COVID-19 pandemic].

Authors:  Ivonne Panchyrz; Solveig Pohl; Julia Hoffmann; Carina Gatermann; Felix Walther; Lorenz Harst; Hanns-Christoph Held; Christian Kleber; Michael Albrecht; Jochen Schmitt
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2021-11-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.